Peter Loof Møller

Peter Loof Møller

Auto-generated profile, based on publicly available information

Peter Loof Møller

Department of Health Science and Technology, Aalborg University, Denmark

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NRNilufer Rahmioglu
Nilufer Rahmioglu
SMSally Mortlock
Sally Mortlock
MGMarzieh Ghiasi
Marzieh Ghiasi
PMPeter L Møller
Peter L Møller
LSLilja Stefansdottir
Lilja Stefansdottir
KZKrina Zondervan
Krina Zondervan

19 January 2024 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
LCLaura Carramolino
Laura Carramolino
Julián Albarrán-JuárezJulián Albarrán-Juárez
Julián Albarrán-Juárez
AMAnton Markov
Anton Markov
EHEsther Hernandez-SanMiguel
Esther Hernandez-SanMiguel
DSDiana Sharysh
Diana Sharysh
JBJacob F. Bentzon
Jacob F. Bentzon

4 February 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MCMorten Krogh Christiansen
Morten Krogh Christiansen
LNLouise Nissen
Louise Nissen
SWSimon Winther
Simon Winther
PMPeter Loof Møller
Peter Loof Møller
LFLars Frost
Lars Frost
MNMette Nyegaard
Mette Nyegaard
Background: Polygenic risk scores ( PRS s) based on risk variants from genome‐wide association studies predict coronary artery disease ( CAD ) risk. However, it is unknown whether the PRS is associated with specific CAD characteristics. Methods and Results: We consecutively included 1645 patients with suspected stable CAD undergoing coronary computed tomography angiography. A multilocus PRS was calculated as the weighted sum of CAD risk variants. Plaques were evaluated using an 18‐segment model and characterized by stenosis severity and composition (soft [0%‐19% calcified], mixed‐soft [20%‐49% calcified], mixed‐calcified [50%‐79% calcified], or calcified [≥80% calcified]). Coronary artery calcium score and segment stenosis score were used to characterize plaque burden. For each standard deviation increase in the PRS , coronary artery calcium score increased by 78% ( P =4.1e‐26) and segment stenosis score increased by 16% ( P =2.4e‐29) in the fully adjusted model. The PRS was associated with a higher prevalence of obstructive plaques (odds ratio [ OR ] : 1.78, P =5.6e‐16), calcified ( OR : 1.69, P =6.5e‐17), mixed‐calcified ( OR : 1.67, P =7.3e‐9), mixed‐soft ( OR : 1.45, P =1.6e‐6), and soft plaques ( OR : 1.49, P =2.5e‐6), and a higher prevalence of plaque in each coronary vessel (all P <1.0e‐4). However, when analyzing data on a plaque level (3007 segments with plaque in 849 patients) the PRS was not associated with stenosis severity, plaque composition, or localization (all P >0.05). Conclusions: Our results suggest that polygenic risk based on large genome‐wide association studies increases CAD risk through an increased burden of coronary atherosclerosis rather than promoting specific plaque features. Clinical Trial Registration: URL : https://www.clinicaltrials.gov . Unique identifier: NCT 02264717.

21 May 2025 in Nature
Verified
Journal Article
Open access
PDF file
GAGudny A. Arnadottir
Gudny A. Arnadottir
HJHakon Jonsson
Hakon Jonsson
THTanja Schlaikjær Hartwig
Tanja Schlaikjær Hartwig
JGJennifer R. Gruhn
Jennifer R. Gruhn
PMPeter Loof Møller
Peter Loof Møller
KSKari Stefansson
Kari Stefansson
Every generation, the human genome is shuffled during meiosis and a single fertilized egg gives rise to all of the cells of the body1. Meiotic errors leading to chromosomal abnormalities are known causes of pregnancy loss2,3, but genetic aetiologies of euploid pregnancy loss remain largely unexplained4. Here we characterize sequence diversity in early pregnancy loss through whole-genome sequencing of 1,007 fetal samples and 934 parental samples from 467 trios affected by pregnancy loss (fetus, mother and father). Sequenced parental genomes enabled us to determine both the parental and meiotic origins of chromosomal abnormalities, detected in half of our set. It further enabled us to assess de novo mutations on both homologous chromosomes from parents transmitting extra chromosomes, and date them, revealing that 6.6% of maternal mutations occurred before sister chromatid formation in fetal oocytes. We find a similar number of de novo mutations in the trios affected by pregnancy loss as in 9,651 adult trios, but three times the number of pathogenic small (<50 bp) sequence variant genotypes in the loss cases compared with adults. Overall, our findings indicate that around 1 in 136 pregnancies is lost due to a pathogenic small sequence variant genotype in the fetus. Our results highlight the vast sequence diversity that is lost in early pregnancy.

17 September 2018 in BMC Genomics
Verified
Journal Article
Open access
PDF file
ASAnita T. Simonsen
Anita T. Simonsen
MHMarcus Høy Hansen
Marcus Høy Hansen
EKEigil Kjeldsen
Eigil Kjeldsen
PMPeter L. Møller
Peter L. Møller
JHJohnny J. Hindkjær
Johnny J. Hindkjær
AAAnni Aggerholm
Anni Aggerholm
The current literature on single cell genomic analyses on the DNA level is conflicting regarding requirements for cell quality, amplification success rates, allelic dropouts and resolution, lacking a systematic comparison of multiple cell input down to the single cell. We hypothesized that such a correlation assay would provide an approach to address the latter issues, utilizing the leukemic cell line OCI-AML3 with a known set of genetic aberrations. By analyzing single and multiple cell replicates (2 to 50 cells) purified by micromanipulation and serial dilution we stringently assessed the signal-to-noise ratio (SNR) from single as well as a discrete number of cells based on a multiple displacement amplification method, with whole exome sequencing as signal readout. In this setting, known OCI-AML3 mutations as well as large copy number alterations could be identified, adding to the current knowledge of cytogenetic status. The presence of DNMT3A R882C, NPM1 W288 fs and NRAS Q61L was consistent, in spite of uneven allelic read depths. In contrast, at the level of single cells, we observed that one-third to half of all variants were not reproduced in the replicate sample, and this allelic mismatch displayed an exponential function of cell input. Large signature duplications were discernible from 5 cells, whereas deletions were visible down to the single cell. Thus, even under highly optimized conditions, single cell whole genome amplification and interpretation must be taken with considerable caution, given that allelic change is frequent and displays low SNR. Allelic noise is rapidly alleviated with increased cell input, and the SNR is doubled from 2 to 50 cells. In conclusion, we demonstrate noisy allele distributions, when analyzing genetic aberrations within single cells relative to multiple cells. Based on the presented data we recommend that single cell analyses should include replicate cell dilution assays for a given setup for relative assessment of procedure-specific SNR to ensure that the resolution supports the specific hypotheses.

1 June 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
MCMorten Krogh Christiansen
Morten Krogh Christiansen
SWSimon Winther
Simon Winther
LNLouise Nissen
Louise Nissen
BVBjarni Jóhann Vilhjálmsson
Bjarni Jóhann Vilhjálmsson
LFLars Frost
Lars Frost
MNMette Nyegaard
Mette Nyegaard
Background: Polygenic risk scores (PRSs) are associated with coronary artery disease (CAD), but the clinical potential of using PRSs at the single-patient level for risk stratification has yet to be established. We investigated whether adding a PRS to clinical risk factors (CRFs) improves risk stratification in patients referred to coronary computed tomography angiography on a suspicion of obstructive CAD. Methods: In this prespecified diagnostic substudy of the Dan-NICAD trial (Danish study of Non-Invasive testing in Coronary Artery Disease), we included 1617 consecutive patients with stable chest symptoms and no history of CAD referred for coronary computed tomography angiography. CRFs used for risk stratification were age, sex, symptoms, prior or active smoking, antihypertensive treatment, lipid-lowering treatment, and diabetes. In addition, patients were genotyped, and their PRSs were calculated. All patients underwent coronary computed tomography angiography. Patients with a suspected ≥50% stenosis also underwent invasive coronary angiography with fractional flow reserve. A combined end point of obstructive CAD was defined as a visual invasive coronary angiography stenosis >90%, fractional flow reserve 50% if fractional flow reserve measurements were not feasible. Results: The PRS was associated with obstructive CAD independent of CRFs (adjusted odds ratio, 1.8 [95% CI, 1.5–2.2] per SD). The PRS had an area under the curve of 0.63 (0.59–0.68), which was similar to that for age and sex. Combining the PRS with CRFs led to a CRF+PRS model with area under the curve of 0.75 (0.71–0.79), which was 0.04 more than the CRF model ( P =0.0029). By using pretest probability (pretest probability) cutoffs at 5% and 15%, a net reclassification improvement of 15.8% ( P =3.1×10 −4 ) was obtained, with a down-classification of risk in 24% of patients (211 of 862) in whom the pretest probability was 5% to 15% based on CRFs alone. Conclusions: Adding a PRS improved risk stratification of obstructive CAD beyond CRFs, suggesting a modest clinical potential of using PRSs to guide diagnostic testing in the contemporary clinical setting. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02264717.